Min Pa: Min Pa(max): Activity's type:

Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max
	0.957	0.003	0.967	Anticonvulsant	0.939 0.003 DBMET01730 0.896 0.004 DBMET00933 0.967 0.003 DBMET03600	DBMET03600
	0.678	0.002	0.808	Benzodiazepine agonist	0.766 0.002 DBMET01730 0.736 0.002 DBMET00933 0.808 0.001 DBMET03600	DBMET03600
	0.501	0.026	0.683	GABA C receptor rho-3 antagonist	0.641 0.005 DBMET01730 0.683 0.004 DBMET00933 0.369 0.076 DBMET03600	DBMET00933
	0.473	0.024	0.473	Nootropic	0.467 0.025 DBMET01730 0.236 0.121 DBMET00933
	0.262	0.009	0.776	GABA receptor agonist	0.649 0.003 DBMET01730 0.665 0.003 DBMET00933 0.776 0.003 DBMET03600	DBMET03600
	0.295	0.077	0.295	Interleukin 2 agonist
	0.157	0.008	0.796	GABA A receptor antagonist	0.646 0.003 DBMET01730 0.796 0.002 DBMET00933 0.682 0.003 DBMET03600	DBMET00933
	0.183	0.036	0.375	Sodium channel (voltage-gated) blocker	0.375 0.004 DBMET01730 0.242 0.017 DBMET00933 0.198 0.03 DBMET03600	DBMET01730
	0.153	0.009	0.803	GABA receptor antagonist	0.638 0.003 DBMET01730 0.803 0.002 DBMET00933 0.679 0.003 DBMET03600	DBMET00933
	0.231	0.094	0.363	Interleukin agonist	0.322 0.038 DBMET01730 0.363 0.026 DBMET00933	DBMET00933
	0.169	0.036	0.212	Nav1.6 sodium channel blocker	0.212 0.016 DBMET01730 0.156 0.047 DBMET00933 0.212 0.016 DBMET03600	DBMET03600
	0.158	0.04	0.163	Pregnane X receptor agonist	0.154 0.046 DBMET01730 0.163 0.033 DBMET00933 0.124 0.116 DBMET03600	DBMET00933
	0.117	0.005	0.155	Secretase gamma inhibitor	0.155 0.004 DBMET01730 0.044 0.029 DBMET00933 0.122 0.005 DBMET03600	DBMET01730
	0.16	0.051	0.372	Sodium channel blocker	0.372 0.005 DBMET01730 0.228 0.024 DBMET00933 0.165 0.047 DBMET03600	DBMET01730
	0.116	0.012	0.167	Cannabinoid CB1 receptor antagonist	0.167 0.006 DBMET01730 0.076 0.03 DBMET00933 0.067 0.037 DBMET03600	DBMET01730
	0.113	0.024	0.274	Cannabinoid receptor antagonist	0.274 0.005 DBMET01730 0.073 0.046 DBMET00933 0.081 0.039 DBMET03600	DBMET01730
	0.092	0.004	0.123	Calcitonin gene-related peptide 1 receptor antagonist	0.123 0.003 DBMET01730 0.096 0.004 DBMET03600	DBMET01730
	0.119	0.033	0.358	Potassium channel activator	0.204 0.008 DBMET01730 0.221 0.007 DBMET00933 0.358 0.004 DBMET03600	DBMET03600
	0.174	0.091	0.463	Anesthetic general	0.415 0.015 DBMET01730 0.333 0.027 DBMET00933 0.463 0.01 DBMET03600	DBMET03600
	0.117	0.035	0.118	Potassium channel (Voltage-sensitive) activator	0.118 0.033 DBMET01730 0.084 0.079 DBMET00933	DBMET01730
	0.151	0.072	0.318	GABA C receptor rho-2 antagonist	0.242 0.013 DBMET01730 0.318 0.005 DBMET00933 0.124 0.118 DBMET03600	DBMET00933
	0.083	0.005	0.087	Pregnane X receptor antagonist	0.087 0.005 DBMET01730 0.065 0.021 DBMET00933 0.077 0.008 DBMET03600	DBMET01730
	0.18	0.107	0.387	Potassium channel blocker	0.387 0.025 DBMET01730	DBMET01730
	0.065	0.005	0.076	Calcitonin gene-related peptide antagonist	0.074 0.004 DBMET01730 0.076 0.004 DBMET03600	DBMET03600
	0.114	0.065	0.2	Calcium channel (voltage-sensitive) blocker	0.2 0.017 DBMET01730 0.106 0.075 DBMET03600	DBMET01730
	0.08	0.033	0.199	Nav1.7 sodium channel blocker	0.199 0.006 DBMET01730 0.101 0.023 DBMET00933 0.08 0.033 DBMET03600	DBMET01730
	0.055	0.018	0.201	Benzodiazepine antagonist	0.144 0.003 DBMET01730 0.201 0.003 DBMET00933 0.068 0.008 DBMET03600	DBMET00933
	0.135	0.098	0.164	MAP kinase kinase 4 inhibitor	0.146 0.07 DBMET01730 0.164 0.04 DBMET00933 0.141 0.083 DBMET03600	DBMET00933
	0.085	0.05	0.099	Transforming growth factor beta 3 antagonist	0.086 0.046 DBMET01730 0.099 0.024 DBMET00933	DBMET00933
	0.062	0.031	0.062	Aldose reductase inhibitor
	0.063	0.036	0.108	Potassium channel intermediate-conductance Ca-activated blocker	0.108 0.007 DBMET01730 0.082 0.016 DBMET00933	DBMET01730
	0.068	0.043	0.113	MDM2 inhibitor	0.076 0.025 DBMET01730 0.113 0.004 DBMET00933	DBMET00933
	0.039	0.017	0.039	Purinergic P2Y2 antagonist
	0.038	0.017	0.077	Benzodiazepine receptor peripheral-type antagonist	0.063 0.005 DBMET01730 0.071 0.004 DBMET00933 0.077 0.004 DBMET03600	DBMET03600
	0.129	0.112	0.151	Polo-like kinase-3 inhibitor	0.151 0.083 DBMET00933	DBMET00933
	0.101	0.089	0.143	Beta amyloid protein antagonist	0.143 0.046 DBMET01730	DBMET01730
	0.038	0.03	0.196	Cholecystokinin antagonist	0.106 0.008 DBMET01730 0.099 0.008 DBMET00933 0.196 0.005 DBMET03600	DBMET03600
	0.093	0.086	0.095	5 Hydroxytryptamine antagonist	0.095 0.084 DBMET01730	DBMET01730
	0.074	0.068	0.085	MAP kinase 7 inhibitor	0.085 0.03 DBMET01730 0.076 0.06 DBMET03600	DBMET01730
	0.028	0.026	0.028	Liver X receptor antagonist	0.028 0.026 DBMET01730
	0.106	0.105	0.229	Calcium channel blocker	0.229 0.021 DBMET01730	DBMET01730
	0.034	0.034	0.102	Delayed rectifier potassium channel blocker	0.102 0.004 DBMET01730 0.043 0.017 DBMET03600	DBMET01730
	0.058	0.058	0.082	5 Hydroxytryptamine 3A antagonist	0.082 0.029 DBMET01730	DBMET01730
	0.032	0.033	0.042	Potassium channel KCNQ activator	0.042 0.021 DBMET01730	DBMET01730
	0.032	0.033	0.042	Delayed rectifier potassium channel activator	0.042 0.021 DBMET01730	DBMET01730
	0.031	0.032	0.039	p53 inhibitor	0.037 0.023 DBMET01730 0.039 0.021 DBMET00933	DBMET00933
	0.073	0.078	0.21	GABA A receptor agonist	0.133 0.019 DBMET01730 0.21 0.009 DBMET00933	DBMET00933
	0.047	0.055	0.109	Cannabinoid CB1 receptor agonist	0.109 0.017 DBMET01730	DBMET01730
	0.026	0.036	0.108	Cholecystokinin A antagonist	0.081 0.012 DBMET01730 0.108 0.007 DBMET00933	DBMET00933
	0.036	0.05	0.125	Cannabinoid CB2 receptor antagonist	0.125 0.01 DBMET01730	DBMET01730
	0.142	0.158	0.219	Antiamyloidogenic	0.219 0.087 DBMET01730	DBMET01730
	0.093	0.108	0.127	Calcium channel N-type blocker	0.127 0.055 DBMET01730 0.12 0.063 DBMET00933	DBMET01730
	0.047	0.063	0.078	Calcium channel T-type blocker	0.078 0.023 DBMET01730 0.061 0.036 DBMET03600	DBMET01730
	0.036	0.059	0.257	Purinergic P2X4 antagonist	0.07 0.009 DBMET01730 0.257 0.003 DBMET00933	DBMET00933
	0.056	0.079	0.064	Calcium channel P-type blocker	0.064 0.044 DBMET01730	DBMET01730
	0.034	0.059	0.145	GABA B receptor antagonist	0.064 0.01 DBMET01730 0.145 0.004 DBMET00933	DBMET00933
	0.032	0.057	0.178	Glutamate (mGluR5) antagonist	0.149 0.005 DBMET01730 0.178 0.005 DBMET00933	DBMET00933
	0.03	0.057	0.064	5 Hydroxytryptamine 2B agonist	0.036 0.033 DBMET01730 0.064 0.007 DBMET00933	DBMET00933
	0.037	0.065	0.072	Benzodiazepine inverse agonist	0.044 0.038 DBMET01730 0.072 0.009 DBMET00933	DBMET00933
	0.073	0.101	0.102	Creatine kinase inhibitor	0.102 0.057 DBMET01730 0.093 0.068 DBMET03600	DBMET01730
	0.074	0.106	0.117	Lanosterol 14 alpha demethylase inhibitor	0.117 0.034 DBMET00933	DBMET00933
	0.165	0.201	0.295	Gastrin inhibitor	0.246 0.084 DBMET01730 0.295 0.036 DBMET00933	DBMET00933
	0.081	0.116	0.171	MAP kinase 13 inhibitor	0.096 0.087 DBMET01730 0.171 0.028 DBMET00933	DBMET00933
	0.04	0.078	0.068	TRPA1 antagonist	0.068 0.034 DBMET01730 0.06 0.044 DBMET00933	DBMET01730
	0.101	0.143	0.138	Mannose-6-phosphate isomerase inhibitor	0.115 0.109 DBMET01730 0.138 0.077 DBMET00933	DBMET00933
	0.02	0.063	0.06	Kinesin-like protein 1 inhibitor	0.06 0.014 DBMET00933	DBMET00933
	0.02	0.063	0.06	Kinesin antagonist	0.06 0.014 DBMET00933	DBMET00933
	0.119	0.162	0.299	Aryl hydrocarbon receptor agonist	0.299 0.061 DBMET00933	DBMET00933
	0.016	0.061	0.038	Progesterone antagonist	0.033 0.026 DBMET01730 0.038 0.023 DBMET00933	DBMET00933
	0.033	0.079	0.046	Alpha 1L adrenoreceptor agonist	0.046 0.023 DBMET00933	DBMET00933
	0.01	0.057	0.138	Cholecystokinin B antagonist	0.039 0.015 DBMET01730 0.028 0.024 DBMET00933 0.138 0.005 DBMET03600	DBMET03600
	0.045	0.092	0.097	5 Hydroxytryptamine 5A antagonist	0.056 0.054 DBMET01730 0.097 0.016 DBMET00933	DBMET00933
	0.031	0.081	0.083	5 Hydroxytryptamine 2 agonist	0.083 0.014 DBMET00933	DBMET00933
	0.144	0.195	0.219	MAP-kinase-activated kinase 5 inhibitor	0.171 0.146 DBMET01730 0.166 0.156 DBMET00933 0.219 0.083 DBMET03600	DBMET03600
	0.087	0.139	0.113	NADPH oxidase inhibitor	0.113 0.092 DBMET00933	DBMET00933
	0.041	0.093	0.094	5 Hydroxytryptamine 5 antagonist	0.094 0.016 DBMET00933	DBMET00933
	0.071	0.125	0.228	5 Hydroxytryptamine 3A agonist	0.125 0.052 DBMET01730 0.228 0.009 DBMET00933	DBMET00933
	0.102	0.158	0.168	NOS3 expression enhancer	0.168 0.057 DBMET01730 0.157 0.066 DBMET00933 0.125 0.105 DBMET03600	DBMET01730
	0.049	0.105	0.08	Transforming growth factor antagonist	0.08 0.035 DBMET00933	DBMET00933
	0.029	0.087	0.161	Phosphodiesterase 2A inhibitor	0.128 0.005 DBMET01730 0.161 0.005 DBMET00933	DBMET00933
	0.033	0.092	0.172	Phosphodiesterase II inhibitor	0.138 0.006 DBMET01730 0.172 0.005 DBMET00933	DBMET00933
	0.058	0.117	0.191	Falcipain 2 inhibitor	0.184 0.017 DBMET01730 0.191 0.015 DBMET00933	DBMET00933
	0.118	0.178	0.239	ATPase inhibitor	0.189 0.048 DBMET01730 0.239 0.017 DBMET00933	DBMET00933
	0.059	0.121	0.192	Falcipain inhibitor	0.185 0.019 DBMET01730 0.192 0.017 DBMET00933	DBMET00933
	0.075	0.138	0.171	MAP kinase 12 inhibitor	0.171 0.032 DBMET00933	DBMET00933
	0.065	0.128	0.143	DNA directed RNA polymerase inhibitor	0.143 0.026 DBMET00933	DBMET00933
	0.178	0.242	0.214	Ca(v)3.3 blocker	0.214 0.163 DBMET01730	DBMET01730
	0.099	0.165	0.188	TRKC antagonist	0.188 0.074 DBMET00933	DBMET00933
	0.07	0.136	0.104	Glutamate release inhibitor	0.104 0.037 DBMET00933	DBMET00933
	0.025	0.093	0.06	Bromodomain-containing protein 3 inhibitor	0.06 0.02 DBMET00933	DBMET00933
	0.098	0.165	0.17	Cyclin-dependent kinase 8 inhibitor	0.16 0.07 DBMET01730 0.17 0.061 DBMET00933	DBMET00933
	0.042	0.118	0.074	Nav1.8 sodium channel blocker	0.074 0.05 DBMET01730	DBMET01730
	0.024	0.101	0.056	Dihydroorotase inhibitor	0.056 0.019 DBMET00933	DBMET00933
	0.065	0.143	0.18	GABA C receptor rho-1 antagonist	0.119 0.041 DBMET01730 0.18 0.012 DBMET00933	DBMET00933
	0.042	0.12	0.266	Glutamate (mGluR group I) antagonist	0.188 0.009 DBMET01730 0.266 0.005 DBMET00933	DBMET00933
	0.068	0.147	0.283	GABA C receptor antagonist	0.131 0.042 DBMET01730 0.283 0.005 DBMET00933	DBMET00933
	0.029	0.108	0.105	Cannabinoid receptor agonist	0.105 0.024 DBMET01730	DBMET01730
	0.012	0.097	0.032	Potassium channel small-conductance Ca-activated activator	0.032 0.021 DBMET00933	DBMET00933
	0.04	0.126	0.083	Corticotropin releasing factor 2 receptor antagonist	0.083 0.015 DBMET00933	DBMET00933
	0.06	0.149	0.156	Bromodomain-containing protein 2 inhibitor	0.086 0.063 DBMET01730 0.156 0.007 DBMET00933	DBMET00933
	0.027	0.119	0.05	5 Hydroxytryptamine 3 antagonist	0.05 0.049 DBMET01730	DBMET01730
	0.028	0.121	0.071	Phosphodiesterase VII inhibitor	0.071 0.034 DBMET00933	DBMET00933
	0.031	0.127	0.116	Prostaglandin-E synthase inhibitor	0.116 0.021 DBMET00933	DBMET00933
	0.03	0.126	0.056	Androgen agonist	0.056 0.046 DBMET01730	DBMET01730
	0.025	0.126	0.053	Transforming growth factor beta 1 antagonist	0.053 0.031 DBMET00933	DBMET00933
	0.158	0.262	0.288	5 Hydroxytryptamine uptake stimulant	0.288 0.052 DBMET00933	DBMET00933
	0.041	0.145	0.099	Potassium channel large-conductance Ca-activated activator	0.099 0.024 DBMET00933	DBMET00933
	0.032	0.137	0.078	5 Hydroxytryptamine 2A antagonist	0.078 0.06 DBMET00933	DBMET00933
	0.225	0.331	0.442	Ca2+/calmodulin-dependent protein kinase kinase A inhibitor	0.368 0.131 DBMET01730 0.442 0.067 DBMET00933 0.277 0.245 DBMET03600	DBMET00933
	0.096	0.202	0.314	HERG channel blocker	0.314 0.045 DBMET01730	DBMET01730
	0.027	0.134	0.075	Purinergic P2 antagonist	0.075 0.036 DBMET01730 0.063 0.045 DBMET00933	DBMET01730
	0.025	0.133	0.107	Pim-2 kinase inhibitor	0.107 0.013 DBMET00933	DBMET00933
	0.069	0.178	0.133	Nav1.5 sodium channel blocker	0.133 0.04 DBMET01730 0.112 0.065 DBMET00933 0.099 0.087 DBMET03600	DBMET01730
	0.048	0.159	0.134	Pim-3 kinase inhibitor	0.134 0.024 DBMET00933	DBMET00933
	0.038	0.151	0.278	Glutamate (mGluR) antagonist	0.216 0.009 DBMET01730 0.278 0.005 DBMET00933	DBMET00933
	0.124	0.239	0.281	5 Hydroxytryptamine release stimulant	0.281 0.076 DBMET00933	DBMET00933
	0.02	0.136	0.057	Acid-sensing ion channel blocker	0.057 0.011 DBMET00933	DBMET00933
	0.047	0.164	0.151	Pim-1 kinase inhibitor	0.151 0.027 DBMET00933	DBMET00933
	0.084	0.201	0.536	Sigma receptor agonist	0.536 0.007 DBMET01730 0.436 0.017 DBMET00933	DBMET01730
	0.017	0.137	0.08	Cannabinoid CB2 receptor agonist	0.08 0.026 DBMET01730	DBMET01730
	0.031	0.154	0.063	5 Hydroxytryptamine 7 agonist	0.063 0.027 DBMET00933	DBMET00933
	0.044	0.177	0.093	5 Hydroxytryptamine 2 antagonist	0.093 0.078 DBMET00933	DBMET00933
	0.128	0.264	0.217	RNA-directed DNA polymerase inhibitor	0.217 0.077 DBMET00933	DBMET00933
	0.034	0.174	0.075	Aryl hydrocarbon receptor antagonist	0.075 0.032 DBMET00933	DBMET00933
	0.032	0.175	0.056	Potassium channel (Ca-activated) blocker	0.056 0.05 DBMET00933	DBMET00933
	0.02	0.168	0.05	Adenylate cyclase 1 inhibitor	0.05 0.026 DBMET00933	DBMET00933
	0.024	0.178	0.054	Potassium channel (ATP-sensitive) activator	0.054 0.024 DBMET00933	DBMET00933
	0.026	0.182	0.056	Potassium channel (Inward rectifier) activator	0.056 0.025 DBMET00933	DBMET00933
	0.033	0.191	0.21	Potassium channel (Ca-activated) activator	0.21 0.013 DBMET00933	DBMET00933
	0.05	0.211	0.127	Nav1.3 sodium channel blocker	0.127 0.066 DBMET00933	DBMET00933
	0.081	0.242	0.316	Potassium channel (Voltage-sensitive) blocker	0.316 0.045 DBMET01730	DBMET01730
	0.053	0.216	0.119	Tyrosine-protein kinase receptor antagonist	0.119 0.088 DBMET00933	DBMET00933
	0.013	0.177	0.061	Factor XIa inhibitor	0.061 0.012 DBMET00933	DBMET00933
	0.123	0.286	0.261	ErbB-1 antagonist	0.261 0.046 DBMET00933	DBMET00933
	0.052	0.215	0.1	Electrolyte absorption antagonist	0.095 0.065 DBMET00933 0.1 0.058 DBMET03600	DBMET03600
	0.029	0.195	0.086	5 Hydroxytryptamine 2C antagonist	0.086 0.056 DBMET00933	DBMET00933
	0.016	0.185	0.067	Purinergic P2X antagonist	0.067 0.019 DBMET01730 0.059 0.024 DBMET00933	DBMET01730
	0.028	0.2	0.094	Phospholipase D inhibitor	0.094 0.019 DBMET00933	DBMET00933
	0.134	0.306	0.178	5 Hydroxytryptamine 3E antagonist	0.178 0.111 DBMET00933	DBMET00933
	0.02	0.192	0.088	5 Hydroxytryptamine 2A agonist	0.088 0.021 DBMET00933	DBMET00933
	0.021	0.194	0.109	MAP kinase 11 inhibitor	0.109 0.03 DBMET00933	DBMET00933
	0.069	0.245	0.142	Protein kinase (CK1) gamma 3 inhibitor	0.142 0.099 DBMET00933	DBMET00933
	0.049	0.226	0.138	MAP kinase kinase 1 inhibitor	0.138 0.021 DBMET00933	DBMET00933
	0.088	0.269	0.364	Ca2+/calmodulin-dependent kinase II beta inhibitor	0.16 0.116 DBMET01730 0.364 0.02 DBMET00933	DBMET00933
	0.047	0.23	0.107	Beta glucuronidase inhibitor	0.107 0.06 DBMET00933	DBMET00933
	0.013	0.198	0.041	RNA-directed RNA polymerase inhibitor	0.041 0.018 DBMET03600	DBMET03600
	0.045	0.231	0.097	Protein kinase C zeta inhibitor	0.097 0.054 DBMET00933 0.082 0.081 DBMET03600	DBMET00933
	0.033	0.22	0.124	Glycine receptor antagonist	0.124 0.016 DBMET00933	DBMET00933
	0.044	0.235	0.116	TRKA antagonist	0.116 0.07 DBMET00933	DBMET00933
	0.019	0.215	0.071	MAP kinase 14 inhibitor	0.071 0.054 DBMET00933	DBMET00933
	0.047	0.246	0.111	Alkaline phosphatase inhibitor	0.111 0.098 DBMET00933	DBMET00933
	0.136	0.337	0.507	Analgesic	0.507 0.047 DBMET01730 0.335 0.117 DBMET00933 0.46 0.062 DBMET03600	DBMET01730
	0.081	0.283	0.135	MAP kinase 3 inhibitor	0.135 0.095 DBMET00933	DBMET00933
	0.064	0.267	0.203	LIM domain kinase 1 inhibitor	0.203 0.061 DBMET00933	DBMET00933
	0.048	0.261	0.474	Psychostimulant	0.358 0.03 DBMET01730 0.451 0.016 DBMET00933 0.474 0.013 DBMET03600	DBMET03600
	0.019	0.237	0.067	Protein kinase C beta inhibitor	0.063 0.062 DBMET00933 0.067 0.054 DBMET03600	DBMET03600
	0.014	0.233	0.071	p38 MAP kinase inhibitor	0.071 0.044 DBMET00933	DBMET00933
	0.056	0.28	0.171	Interleukin 8 antagonist	0.111 0.075 DBMET01730 0.171 0.023 DBMET00933	DBMET00933
	0.066	0.291	0.295	MAP kinase kinase 2 inhibitor	0.295 0.037 DBMET00933	DBMET00933
	0.03	0.257	0.129	Platelet activating factor antagonist	0.129 0.057 DBMET00933	DBMET00933
	0.005	0.234	0.04	Factor XI inhibitor	0.04 0.016 DBMET00933	DBMET00933
	0.091	0.321	0.217	Death-associated protein kinase 2 inhibitor	0.217 0.024 DBMET00933	DBMET00933
	0.061	0.296	0.122	Thiol protease inhibitor	0.122 0.113 DBMET00933	DBMET00933
	0.051	0.287	0.118	Protein kinase (CK1) gamma 1 inhibitor	0.118 0.1 DBMET00933	DBMET00933
	0.035	0.272	0.106	5 Hydroxytryptamine 2B antagonist	0.106 0.077 DBMET00933	DBMET00933
	0.104	0.359	0.351	Antiobesity	0.351 0.087 DBMET01730	DBMET01730
	0.025	0.281	0.106	Phosphodiesterase 3A inhibitor	0.106 0.028 DBMET00933	DBMET00933
	0.059	0.316	0.102	Transcription factor STAT6 inhibitor	0.102 0.1 DBMET00933	DBMET00933
	0.005	0.266	0.028	HCV NS5B polymerase inhibitor	0.028 0.027 DBMET03600	DBMET03600
	0.009	0.273	0.055	Adenosine A2b receptor antagonist	0.055 0.028 DBMET00933	DBMET00933
	0.027	0.307	0.425	Glutamate receptor antagonist	0.25 0.015 DBMET01730 0.425 0.005 DBMET00933	DBMET00933
	0.034	0.314	0.129	Proto-oncogene tyrosine-protein kinase Yes inhibitor	0.129 0.075 DBMET00933	DBMET00933
	0.031	0.311	0.112	Ferrochelatase inhibitor	0.112 0.06 DBMET00933	DBMET00933
	0.031	0.312	0.189	MAP kinase kinase inhibitor	0.189 0.032 DBMET00933	DBMET00933
	0.023	0.305	0.057	Phosphodiesterase 1A inhibitor	0.057 0.048 DBMET00933	DBMET00933
	0.023	0.308	0.054	Antiviral (Hepatitis D)	0.054 0.029 DBMET00933	DBMET00933
	0.02	0.304	0.104	Cyclin B3 inhibitor	0.104 0.027 DBMET00933	DBMET00933
	0.006	0.292	0.088	Glutamate (mGluR1) antagonist	0.088 0.02 DBMET00933	DBMET00933
	0.033	0.32	0.108	Protein kinase (CK1) gamma inhibitor	0.108 0.105 DBMET00933	DBMET00933
	0.061	0.352	0.185	Ca2+/calmodulin-dependent protein kinase inhibitor	0.185 0.085 DBMET00933	DBMET00933
	0.009	0.307	0.048	NMDA receptor subunit 3B antagonist	0.048 0.027 DBMET00933	DBMET00933
	0.017	0.321	0.064	Cyclin D1 inhibitor	0.064 0.037 DBMET00933	DBMET00933
	0.003	0.309	0.036	NMDA receptor glycine site antagonist	0.036 0.009 DBMET00933	DBMET00933
	0.004	0.332	0.032	Kainate receptor 2 antagonist	0.032 0.028 DBMET00933	DBMET00933
	0.021	0.363	0.227	Glycogen synthase kinase-3 alpha inhibitor	0.227 0.034 DBMET00933	DBMET00933
	0.004	0.349	0.047	AMPA receptor antagonist	0.047 0.034 DBMET00933	DBMET00933
	0.096	0.441	0.288	Calcium channel activator	0.288 0.104 DBMET00933	DBMET00933
	0.029	0.378	0.079	GABA B receptor agonist	0.079 0.043 DBMET00933	DBMET00933
	0.022	0.385	0.081	MAP-kinase-activated kinase inhibitor	0.081 0.061 DBMET00933	DBMET00933
	0.043	0.408	0.136	Aurora-C kinase inhibitor	0.136 0.072 DBMET00933	DBMET00933
	0.026	0.4	0.14	Ca2+/calmodulin-dependent kinase II gamma inhibitor	0.14 0.096 DBMET00933	DBMET00933
	0.02	0.406	0.054	Sodium/calcium exchanger inhibitor	0.054 0.027 DBMET00933	DBMET00933
	0.026	0.416	0.143	Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor	0.143 0.126 DBMET00933	DBMET00933
	0.008	0.401	0.078	NMDA receptor glycine site agonist	0.078 0.03 DBMET00933	DBMET00933
	0.035	0.428	0.095	Nav1.1 sodium channel blocker	0.095 0.072 DBMET03600	DBMET03600
	0.019	0.412	0.126	EphA2 antagonist	0.126 0.049 DBMET00933	DBMET00933
	0.092	0.489	0.25	Nitric-oxide synthase stimulant	0.25 0.032 DBMET00933	DBMET00933
	0.014	0.441	0.074	MAP-kinase-activated kinase 2 inhibitor	0.074 0.052 DBMET00933	DBMET00933
	0.021	0.462	0.092	AMP-activated protein kinase stimulant	0.092 0.081 DBMET00933	DBMET00933
	0.033	0.483	0.21	Platelet aggregation inhibitor	0.21 0.074 DBMET00933	DBMET00933
	0.088	0.559	0.283	5 Hydroxytryptamine release inhibitor	0.283 0.186 DBMET00933	DBMET00933
	0.029	0.502	0.116	Cytokine production inhibitor	0.116 0.094 DBMET00933	DBMET00933
	0.05	0.524	0.151	Ca2+/calmodulin-dependent kinase I alpha inhibitor	0.151 0.144 DBMET00933	DBMET00933
	0.04	0.516	0.176	Cardiotonic	0.176 0.144 DBMET01730	DBMET01730
	0.005	0.489	0.104	Phosphodiesterase 3B inhibitor	0.104 0.01 DBMET00933	DBMET00933
	0.06	0.545	0.124	Death-associated protein kinase 1 inhibitor	0.124 0.099 DBMET00933	DBMET00933
	0.023	0.509	0.142	Death-associated protein kinase 3 inhibitor	0.142 0.136 DBMET00933	DBMET00933
	0.018	0.508	0.111	Phosphodiesterase inhibitor	0.111 0.092 DBMET00933	DBMET00933
	0.009	0.499	0.053	Plasminogen activator inhibitor	0.053 0.045 DBMET03600	DBMET03600
	0.005	0.499	0.125	NMDA receptor antagonist	0.125 0.033 DBMET00933	DBMET00933
	0.012	0.539	0.173	Polo-like kinase-4 inhibitor	0.173 0.024 DBMET00933	DBMET00933
	0.026	0.568	0.11	Interleukin 1 antagonist	0.11 0.104 DBMET00933	DBMET00933
	0.007	0.59	0.091	Phosphodiesterase III inhibitor	0.091 0.027 DBMET00933	DBMET00933
	0.028	0.616	0.276	Cyclic AMP phosphodiesterase inhibitor	0.276 0.052 DBMET00933	DBMET00933
	0.045	0.652	0.242	Ca2+/calmodulin-dependent kinase II alpha inhibitor	0.237 0.119 DBMET00933 0.242 0.114 DBMET03600	DBMET03600
	0.048	0.749	0.159	Cyclin-dependent kinase 3 inhibitor	0.159 0.078 DBMET00933	DBMET00933
	0.011	0.798	0.073	Chymotrypsin inhibitor	0.073 0.065 DBMET03600	DBMET03600
	0.013	0.84	0.104	Nav1.4 sodium channel blocker	0.104 0.07 DBMET00933	DBMET00933
	0.049	0.933	0.335	Calcium channel L-type activator	0.335 0.129 DBMET00933	DBMET00933
	0.001	0.99	0.031	1,3-Beta-glucan synthase inhibitor	0.031 0.012 DBMET03600	DBMET03600
Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max